[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@TLwpstkatlqaks ExplosiveRiseExplosiveRise posts on X about short interest, ipo, debt, microsoft the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance XXXXX% stocks XXXX% technology brands XXXX% countries XXXX% travel destinations XXXX% currencies XXXX%
Social topic influence short interest #64, ipo #1005, debt 4.88%, microsoft 4.88%, ceo 4.88%, automation 3.66%, strong 3.66%, robust 2.44%, health 2.44%, balance sheet #2000
Top assets mentioned Microsoft Corp. (MSFT)
Top posts by engagements in the last XX hours
"Low Debt High Retained Earnings: Reduced liabilities and robust accumulated profits support long-term growth"
X Link 2025-11-12T00:36Z XX followers, XX engagements
"Hoffman Agency Korea won three top honors at the 33rd Korea PR Awards including for its global PR campaign for #Seegene. The campaign effectively communicated Seegenes molecular diagnostics technology to global markets enhancing its international brand positioning"
X Link 2025-11-17T11:56Z XX followers, XX engagements
"#Seegenes multiplex PCR enables precise HPV genotyping boosting cervical cancer prevention. Its global role and self-sampling tech improve access advancing WHOs 2030 goal for womens health equity"
X Link 2025-11-18T00:16Z XX followers, XX engagements
"#Seegene our Bronze Sponsor was honored with a special award at #LIFE2025 for their vital support and commitment to advancing lab medicine and healthcare innovation contributing significantly to collaboration learning and innovation throughout the event"
X Link 2025-11-18T04:34Z XX followers, XX engagements
"#Seegene is revolutionizing molecular diagnostics with syndromic quantitative PCR and AI-powered automation. Strategic alliances with #Microsoft and #SpringerNature drive early accurate disease detection and next-gen diagnostic innovation"
X Link 2025-11-18T06:54Z XX followers, XXX engagements
"In Q3 2025 #Seegene ranked 2nd in South Koreas medical device market with $174.4M revenue and returned to profit via non-COVID diagnostics. Yet its $910M market cap lags far behind PharmaResearchs $3.22B highlighting a potential undervaluation"
X Link 2025-11-19T00:02Z XX followers, XX engagements
"As of November XX 2025 #Seegene's net short selling balance stood at 94045 shares accounting for XXXX% of the company's total outstanding shares of 52225994"
X Link 2025-11-19T15:05Z XX followers, XX engagements
"On March XX 2024 #Seegene CEO Chun Jong-yoon met #UKHSA Chief Jenny Harries in Seoul to discuss global disease prevention. Harries praised Seegenes pandemic response and showed interest in its AI-driven technology-sharing initiative aimed at developing tailored diagnostics"
X Link 2025-11-20T15:32Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-21T06:19Z XX followers, XX engagements
"#Seegene Medical Foundation launched a CLIA-certified diagnostic center in Gardena California marking its U.S. entry. Subsidiary OpenHealthcare introduced the AllrangeKit self-test service and blood collection sites while partnering with Microsoft Azure AI to build a digital"
X Link 2025-11-24T00:31Z XX followers, XX engagements
"#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation"
X Link 2025-11-24T02:30Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70077 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-24T04:10Z XX followers, XX engagements
"What Is #Seegene's Debt The chart below which you can click on for greater detail shows that #Seegene had 76.8b in debt in June 2025; about the same as the year before. However its balance sheet shows it holds 544.2b in cash so it actually has 467.4b net cash"
X Link 2025-11-25T12:09Z XX followers, XX engagements
"we can see that #Seegene had liabilities of 161.9b due within XX months and liabilities of 56.8b due beyond that. On the other hand it had cash of 544.2b and 95.7b worth of receivables due within a year. So it can boast 421.2b more liquid assets than total liabilities"
X Link 2025-11-25T13:39Z XX followers, XX engagements
"liquidity is a great indication that #Seegene's balance sheet is almost as strong as Fort Knox.On this view lenders should feel as safe as the beloved of a black-belt karate master. Seegene has more cash than debt is arguably a good indication that it can manage its debt safely"
X Link 2025-11-26T01:29Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-26T02:41Z XX followers, XX engagements
"#Seegene shows strong financial health converting EBIT into even higher free cash flow last year. This robust cash generation enhances debt management capacity and reassures shareholders with solid performance"
X Link 2025-11-26T05:00Z XX followers, XX engagements
"#Seegene holds treasury shares worth XXXXX billion KRW XXXX% of issued stock. If mandated cancellation occurs it will signal a firm commitment to restructuring and greater transparency in corporate governance"
X Link 2025-11-28T01:38Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-30T16:07Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-02T01:05Z XX followers, XX engagements
"#Seegenes French subsidiary marks a shift to global localization completing its European JV network with Israel and Spain. Frances regulatory weight boosts standardization of diagnostics while full control in Canada strengthens governance. Seegene pursues localization"
X Link 2025-12-03T14:40Z XX followers, XX engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-03T14:52Z XX followers, XX engagements
"#Seegene partnered with Germanys Epitype to integrate epigenetic biomarker test ScreenYu Gyn into its multiplex PCR portfolio aiming to advance cervical cancer early detection boost patient recovery reduce costs and expand global diagnostic reach"
X Link 2025-12-04T01:29Z XX followers, XX engagements
"According to the Korea Corporate Reputation Research Institutes big data analysis#Seegene topped Dec 2025 brand reputation among listed life science service firms with JS Link second and Boditech Med third. Overall brand big data rose XXX% from NovSeegenes score grew 15.28%"
X Link 2025-12-04T02:20Z XX followers, XX engagements
"#Seegene has established SEEGENE FRANCE to expand into Western Europe aiming to supply diagnostic reagents and equipment optimized for IVDR compliance and strengthen local networks. The company also launched JVs in Israel and Spain in 2025 while Seegene Canada became a wholly"
X Link 2025-12-04T13:39Z XX followers, XX engagements
"#Seegene opens its 3rd European hub in France targeting major diagnostics markets. Frances strong demand for STI GI and cancer testing plus a private-driven structure favors rapid supply. The subsidiary will launch #CURECA automation and #STAgora platform growth in Europe"
X Link 2025-12-05T00:58Z XX followers, XX engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-05T01:02Z XX followers, XX engagements
"#Seegene Mexico partners with Canadas #Microbix to embed QAPs quality systems into HPV diagnostics boosting accuracy and trust. This strategic move strengthens cervical cancer prevention accelerates lab validation and positions Seegene to expand across Latin America"
X Link 2025-12-05T07:42Z XX followers, XX engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-08T00:56Z XX followers, XX engagements
"Chun Jong-yoon founder & CEO of #Seegene drives global diagnostics innovation. With a Ph.D. in molecular biology he leads tech-sharing initiatives to expand PCR solutions worldwide"
X Link 2025-12-09T00:10Z XX followers, XX engagements
"Chun Jong-YoonCEO of #Seegeneearned his Ph.D. in Molecular Biology from the University of Tennessee in 1994. He then continued his academic journey as a postdoctoral researcher at Harvard University and UC Berkeleywhere he immersed himself in worldclass research environments"
X Link 2025-12-09T12:47Z XX followers, XX engagements
"The remarks of #Seegene CEO Chun Jong-yoon go beyond a simple management message carrying philosophical depth. For example his statement that research and work must be placed on the orbit of habit emphasizes a self-directed attitude toward life"
X Link 2025-12-09T12:50Z XX followers, XX engagements
"Chun Jong-yoon CEO of #Seegene stated that the 2024 strategic partnership with Microsoft goes beyond a simple technology collaboration serving as a stepping stone for the global expansion of the molecular diagnostics platform"
X Link 2025-12-09T12:51Z XX followers, XX engagements
"#Seegene is leading the era of automated molecular diagnostics with its flagship platforms CURECA and STAgora. Guided by the philosophy that diagnostics must be fast and accurate Chairman Chun Jong-yoon has focused on transforming the conventional labor-intensive PCR"
X Link 2025-12-11T00:03Z XX followers, XX engagements
"#Seegenes #CURECA is an automated system robot that performs the entire diagnostic process ranging from sample loading preprocessing nucleic acid extraction amplification to result analysis unmanned XX hours a day"
X Link 2025-12-11T00:30Z XX followers, XX engagements
"Welcome to Seegene. Welcome"
X Link 2025-12-11T04:18Z XX followers, X engagements
"Welcome to #Seegene. Welcome"
X Link 2025-12-11T06:21Z XX followers, X engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-10T00:25Z XX followers, XX engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-11T14:01Z XX followers, X engagements
"#Seegene #CURECA is the worlds first fully automated unmanned PCR system robot. From sample loading to preprocessing nucleic acid extraction amplification and result analysis it performs every step without human intervention greatly enhancing testing efficiency"
X Link 2025-12-12T00:10Z XX followers, XX engagements